If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christopher Triggle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Endothelium Medicine & Life Sciences
Vascular Smooth Muscle Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Smooth Muscle Medicine & Life Sciences
Mesenteric Arteries Medicine & Life Sciences
Acetylcholine Medicine & Life Sciences
Nitric Oxide Medicine & Life Sciences
Nifedipine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1969 2019

6 Citations (Scopus)

Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues

Geng, L., Liao, B., Jin, L., Huang, Z., Triggle, C., Ding, H., Zhang, J., Huang, Y., Lin, Z. & Xu, A., 5 Mar 2019, In : Cell Reports. 26, 10, p. 2738-2752.e4

Research output: Contribution to journalArticle

Open Access
Adipose Tissue
Obesity
Tissue
Crosstalk
Transducers
1 Citation (Scopus)

Impact of currently used anti-diabetic drugs on myoendothelial communication

Ding, H., Ye, K. & Triggle, C., 1 Apr 2019, In : Current Opinion in Pharmacology. 45, p. 1-7 7 p.

Research output: Contribution to journalReview article

Metformin
Endothelium
Pharmaceutical Preparations
Vascular Diseases
Vasodilation
Sodium-Glucose Transport Proteins
Hyperglycemia
Type 2 Diabetes Mellitus
Blood Vessels
Oxidative Stress
1 Citation (Scopus)

Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro

Majeed, Y., Upadhyay, R., Alhousseiny, S., Taha, T., Musthak, A., Shaheen, Y., Jameel, M., Triggle, C. & Ding, H., 1 Dec 2019, In : Scientific reports. 9, 1, 6316.

Research output: Contribution to journalArticle

Open Access
Fenofibrate
Hypolipidemic Agents
Hemangiosarcoma
Peroxisome Proliferator-Activated Receptors
Vascular Endothelial Growth Factor A
Open Access
Thrombospondin 1
Metformin
Deoxyglucose
Up-Regulation
Endothelial Cells